Detalhe da pesquisa
1.
Prognostic evaluation of quick sequential organ failure assessment score in ICU patients with sepsis across different income settings.
Crit Care
; 28(1): 30, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263076
2.
Exploration of immunotherapy in advanced pulmonary lymphoepithelioma-like carcinoma.
Int J Cancer
; 152(11): 2338-2350, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631999
3.
Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials.
Oncologist
; 28(1): e36-e44, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398872
4.
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
BMC Med
; 21(1): 94, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927541
5.
Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy.
BMC Cancer
; 23(1): 72, 2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670414
6.
Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma.
Cancer Control
; 30: 10732748221148912, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592162
7.
Epidemiology, Management, and Outcomes of Sepsis in ICUs among Countries of Differing National Wealth across Asia.
Am J Respir Crit Care Med
; 206(9): 1107-1116, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763381
8.
Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I.
Cancer
; 128(21): 3804-3814, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069292
9.
A Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma.
Oncologist
; 27(6): e453-e462, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445718
10.
Epidermal growth factor receptor-Mutated Non-small-cell Lung Cancer with Intracranial Progressions and Stable Extracranial Diseases Benefit from Osimertinib Regardless of T790M Mutational Status.
Cancer Control
; 29: 10732748221081360, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201951
11.
Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomics.
Acta Pharmacol Sin
; 43(7): 1857-1864, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737420
12.
Comparison of prone positioning and extracorporeal membrane oxygenation in acute respiratory distress syndrome: A multicenter cohort study and propensity-matched analysis.
J Formos Med Assoc
; 121(6): 1149-1158, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740489
13.
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 22(8): 1162-1174, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174189
14.
A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors.
Oncologist
; 26(4): e549-e566, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33105036
15.
Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC.
BMC Med
; 19(1): 239, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615542
16.
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer.
BMC Med
; 19(1): 223, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592968
17.
The perception gap of chemotherapy-induced adverse events between doctors and cancer patients: an observational study in China.
Support Care Cancer
; 29(3): 1543-1548, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728801
18.
Chronic Obstructive Pulmonary Disease as a Phenotype of Bronchiectasis for Long-Term Clinical Presentation and Treatment.
Medicina (Kaunas)
; 57(6)2021 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34198847
19.
KEYNOTE-032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non-Small Cell Lung Cancer.
Oncologist
; 25(8): 650-e1145, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134163
20.
Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma.
Oncologist
; 25(3): e545-e554, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162827